Skip to main content
Livermore
Livermore
ZHEN

Deciphera Pharmaceuticals, Inc.

DCPHDelisted Jun 11, 2024
Industry
Pharmaceutical Preparations
SEC CIK
0001654151

Deciphera Pharmaceuticals, Inc. was delisted on Jun 11, 2024; its insiders filed their last Form 4 on Jun 11, 2024; 177 institutions reported holding it in 13F filings for Q1 2024, worth $943.7M in total; no superinvestor held it.

Holders of 5% or more of DCPH

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Deciphera Pharmaceuticals, Inc., largest stake first. The change is against the holder's previous filing.

No holder currently reports owning 5% or more of Deciphera Pharmaceuticals, Inc. on Schedule 13D or 13G.

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

12 Schedule 13D and 13G filings on Deciphera Pharmaceuticals, Inc., newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on DCPH
Filed (ET)FilerFormStakeChangeEvent dateFiling
Feb 15, 2022Armistice Capital, LLC13GOld format–New–SEC
Feb 14, 2022Redmile Group, LLC13G/AOld format–––SEC
Feb 11, 2022Flynn James E13G/AOld format–––SEC
Feb 9, 2022Vanguard Group Inc13G/AOld format–––SEC
Feb 3, 2022Franklin Resources Inc13G/AOld format–––SEC
Jan 31, 2022Bank of America Corp13GOld format–New–SEC
Jan 10, 2022State Street Corp13GOld format–New–SEC
Nov 10, 2021Flynn James E13GOld format–New–SEC
Feb 16, 2021Redmile Group, LLC13G/AOld format–––SEC
Feb 10, 2021Vanguard Group Inc13GOld format–New–SEC
Feb 2, 20213:13 PM ETBlackRock Inc.13GOld format–New–SEC
Feb 1, 2021Franklin Resources Inc13GOld format–New–SEC

Form 144: proposed insider sales

Notices from officers, directors and other affiliates planning to sell Deciphera Pharmaceuticals, Inc. shares.

No Form 144 notices for Deciphera Pharmaceuticals, Inc. are on file.